Xiaojiang Wu, Ziyu Li, Ziran Li, Yongning Jia, Fei Shan, Xin Ji, Zhaode Bu, Lianhai Zhang, Aiwen Wu, Jiafu Ji
BACKGROUND: Our aim is to evaluate the safety and efficacy of two treatment strategies, hyperthermic intraperitoneal chemotherapy (HIPEC) plus simultaneous versus staged cytoreductive surgery (CRS) in patients with occult peritoneal metastasis of gastric cancer (GC). METHODS: We retrospectively reviewed 26 GC patients who were potential curatively resectable by pre-operative evaluation and found occult peritoneal metastasis by diagnostic laparoscopy. Patients were treated by HIPEC plus either simultaneous CRS (CRS+HIPEC group, n = 11) or staged CRS after systematic chemotherapy (HIPEC+Chemo+CRS group, n = 15)...
June 2015: Journal of Surgical Oncology